- Home
- VIVS vs SBFM Comparison
VIVS vs SBFM Comparison
Compare VIVS & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVS
- SBFM
- Stock Information
- Founded
- VIVS 2007
- SBFM 2006
- Country
- VIVS United States
- SBFM United States
- Employees
- VIVS N/A
- SBFM N/A
- Industry
- VIVS Biotechnology: Biological Products (No Diagnostic Substances)
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- VIVS Health Care
- SBFM Health Care
- Exchange
- VIVS Nasdaq
- SBFM Nasdaq
- Market Cap
- VIVS 8.1M
- SBFM 6.7M
- IPO Year
- VIVS N/A
- SBFM N/A
- Fundamental
- Price
- VIVS $2.28
- SBFM $1.82
- Analyst Decision
- VIVS
- SBFM Strong Buy
- Analyst Count
- VIVS 0
- SBFM 1
- Target Price
- VIVS N/A
- SBFM $7.00
- AVG Volume (30 Days)
- VIVS 1.4M
- SBFM 2.2M
- Earning Date
- VIVS 11-12-2025
- SBFM 11-12-2025
- Dividend Yield
- VIVS N/A
- SBFM N/A
- EPS Growth
- VIVS N/A
- SBFM N/A
- EPS
- VIVS N/A
- SBFM N/A
- Revenue
- VIVS $142,000.00
- SBFM $36,341,741.00
- Revenue This Year
- VIVS $42.38
- SBFM $21.12
- Revenue Next Year
- VIVS $15.42
- SBFM $44.89
- P/E Ratio
- VIVS N/A
- SBFM N/A
- Revenue Growth
- VIVS 94.52
- SBFM 19.22
- 52 Week Low
- VIVS $1.41
- SBFM $1.17
- 52 Week High
- VIVS $21.96
- SBFM $3.90
- Technical
- Relative Strength Index (RSI)
- VIVS 43.02
- SBFM 51.35
- Support Level
- VIVS $2.05
- SBFM $1.61
- Resistance Level
- VIVS $3.20
- SBFM $2.13
- Average True Range (ATR)
- VIVS 0.31
- SBFM 0.12
- MACD
- VIVS -0.02
- SBFM -0.03
- Stochastic Oscillator
- VIVS 20.00
- SBFM 30.81
About VIVS VivoSim Labs Inc. Common Stock
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.